Michael S Mcgrath

Title: Michael S Mcgrath: Innovator in ALS Treatment

Introduction

Michael S Mcgrath is a notable inventor based in Meadow Vista, CA (US), recognized for his contributions to the field of neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS). With a total of 6 patents, Mcgrath has made significant strides in developing treatment methods that aim to improve the quality of life for ALS patients.

Latest Patents

Among his latest patents, Mcgrath has developed innovative treatment methods for ALS patients. These methods involve the use of chlorite or a pharmaceutical composition comprising sodium chlorite, targeting a specific ALS patient population. His research also includes methods for identifying ALS patients who are likely to respond positively to treatment, focusing on those with elevated plasma C-reactive protein (CRP) levels and patients aged 40-65 with sporadic ALS pathology. Additionally, he has described methods for monitoring and treating subjects with ALS based on biomarkers, further enhancing the understanding of this complex disease.

Career Highlights

Throughout his career, Mcgrath has worked with various organizations, including Neuvivo, Inc. and the University of California. His work has been instrumental in advancing research and treatment options for ALS, showcasing his dedication to improving patient outcomes.

Collaborations

Mcgrath has collaborated with notable professionals in the field, including Vernon A Norviel and Arasteh Ari Azhir. These partnerships have contributed to the development of innovative solutions for ALS treatment.

Conclusion

Michael S Mcgrath stands out as a significant figure in the realm of ALS research and treatment. His innovative patents and collaborative efforts reflect his commitment to addressing the challenges faced by ALS patients.